CODX Free Cash Flow from 2010 to 2024

CODX Stock  USD 0.73  0.00  0.000003%   
Co Diagnostics Free Cash Flow yearly trend continues to be fairly stable with very little volatility. Free Cash Flow is likely to outpace its year average in 2024. Free Cash Flow is the amount of cash Co Diagnostics generates after accounting for cash outflows to support operations and maintain its capital assets. View All Fundamentals
 
Free Cash Flow  
First Reported
2016-03-31
Previous Quarter
-5.3 M
Current Value
-7.4 M
Quarterly Volatility
6.2 M
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Free Cash Flow Growth Pattern

Below is the plot of the Free Cash Flow of Co Diagnostics over the last few years. It is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets. Co Diagnostics' Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow10 Years Trend
Very volatile
   Free Cash Flow   
       Timeline  

CODX Free Cash Flow Regression Statistics

Arithmetic Mean193,607
Geometric Mean4,493,132
Coefficient Of Variation8,205
Mean Deviation9,648,427
Median(1,648,836)
Standard Deviation15,886,191
Sample Variance252.4T
Range63.9M
R-Value0
Mean Square Error271.8T
R-Squared0.000011
Significance0.99
Slope12,017
Total Sum of Squares3533.2T

CODX Free Cash Flow History

2024-22.3 M
2023-23.4 M
20225.1 M
202140.4 M
202027.4 M
2019-5.6 M
2018-4.1 M

Other Fundumenentals of Co Diagnostics

Co Diagnostics Free Cash Flow component correlations

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Free Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow-23.4 M-22.3 M
Free Cash Flow Yield(0.60)(0.57)
Free Cash Flow Per Share(0.80)(0.76)
EV To Free Cash Flow(1.16)(1.21)
Price To Free Cash Flows Ratio(1.66)(1.75)
Free Cash Flow Operating Cash Flow Ratio 1.06  1.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.